Abstract
Drug‐loaded liposomes are typical examples of nanomedicines. We show here that doxorubicin, the anti‐cancer agent in the liposomal drug Doxil, can sensitize Ytterbium (Yb3+) and generate its near‐infrared (NIR) emission. When doxorubicin and amphiphilic Yb3+ chelates are incorporated into liposomes, the sensitized emission of Yb3+ is dependent on the integrity of the particles, which can be used to monitor drug release. We also established the first demonstration that the NIR Yb3+ emission signal is observable in living mice following intratumoral injection of the Yb3+‐doxorubicin‐liposomes, using a commercial macroscopic setup equipped with a NIR camera.
Funding Information
  • Ligue Contre le Cancer

This publication has 36 references indexed in Scilit: